血液透析患者的高血压药物控制

doi:10.5246/jcps.2012.03.026

血液透析患者的高血压药物控制

朱孔彩, 曹国颖^*, 胡欣

1. 卫生部北京医院药学部, 北京 100730
2. 北京大学医学部药学院药事管理与临床药学系, 北京 100191

收稿日期:2011-10-19 修回日期:2012-02-10 出版日期:2012-05-15 发布日期:2012-05-15
通讯作者: 曹国颖*

Drug management of hypertension in hemodialysis patients

Kong-Cai Zhu, Guo-Ying Cao^*, Xin Hu

1. Department of Pharmacy, Beijing Hospital, Ministry of Health, Beijing 100730, China
2. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

Received:2011-10-19 Revised:2012-02-10 Online:2012-05-15 Published:2012-05-15
Contact: Guo-Ying Cao*

摘要/Abstract

摘要：

高血压是血液透析患者心、脑血管并发症的重要危险因素。清除体内过量水分, 准确评估患者干体重, 抗高血压药物治疗是目前比较常用的有效控制透析患者高血压、降低心血管事件发生率和病死率的治疗手段。

关键词: 高血压, 血液透析, 终末期肾病

Abstract:

Hypertension is believed to be a major risk factor that causes cardiovascular disease in patients on hemodialysis (HD). Removing of excess water during HD, accurate assessment of dry weight and anti-hypertension therapeutics are the most commonly used measures to lower blood pressure in patients on HD.

Key words: Hypertension, Hemodialysis, End-stage renal disease

中图分类号:

R969

Supporting: ^*Corresponding author. Tel.: 86-10-85133632

朱孔彩, 曹国颖^*, 胡欣. 血液透析患者的高血压药物控制[J]. , DOI: 10.5246/jcps.2012.03.026.

Kong-Cai Zhu, Guo-Ying Cao^*, Xin Hu. Drug management of hypertension in hemodialysis patients [J]. , DOI: 10.5246/jcps.2012.03.026.

参考文献

[1] Li, Z.; Lacson, E.Jr.; Lowrie, E.G.; Kuhlmann, M.K.; Lazarus, J.M.; Levin, N.W. Am. J. Kidney Dis. 2006, 48, 606-615.
[2] Schömig, M.; Eisenhardt, A.; Ritz, E. Nephrol. Dial. Transplant. 2001, 16, 469-474.
[3] Guyton, A.C.; Hall, J.E. Textbook of Medical Physiology. 9^th ed. Philadelphia: W.B. Saunders. 1996.
[4] Koomans, H.A.; Braam, B.; Geers, A.B.; Roos, J.C.; Doorhout Mees, E.J. Kidney Int. 1986, 30, 730-735.
[5] Mailloux, L.U.; Haley, W.E. Am. J. Kidney Dis. 1998, 32, 705-719.
[6] Hörl, M.P.; Hörl, W.H. Am. J. Kidney Dis. 2002, 39, 227-244.
[7] Mitra, S.; Chandna, S.M.; Farrington, K. Nephrol. Dial. Transplant. 1999, 14, 2915-2921.
[8] de Paula, F.M.; Peixoto, A.J.; Pinto, L.V.; Dorigo, D.; Patricio, P.J.; Santos, S.F. Kidney Int. 2004, 66, 1232-1238.
[9] Franz, M.; Pohanka, E.; Tribl, B.; Woloszczuk, W.; Hörl, W.H. Kidney Int. 1997, 51, S39-S42.
[10] Toto, K.H. Crit. Care Nurs. Clin. North. Am. 1998, 10, 383-400.
[11] Pérez-García, R.; López-Gómez, J.M.; Jofre, R.; Junco, E.; Valderrábano, F. Nephrol. Dial. Transplant. 2001, 16, 98-101.
[12] Wendy, P.; Elizabeth, M.; Allison, W.; Rowan, W. Nephrol. Nurs. J. 2004, 31, 631-636.
[13] Daugirdas, J.T.; Blake, P.G.; Ing, T.S. Handbook of Dialysis. 4th ed. USA: Lippincott Williams & Wilkins. 2007.
[14] Faissal, T.; Karima, A.; Meryem, B.; Mohamed, Z.; Ghislaine, M.; Khadija, H.; Mohamed, G.B.; Benyounes, R. Saudi. J. Kidney Dis. Transpl. 2007, 18, 355-360.
[15] Susan, K.F.; Roberto, M.L.; Alex, N.; David, A.B.; Kenneth, M.B. Hypertension. 1989, 13, 213-218.
[16] Gerard, M.L.; Sylvain, J.M.; Alain, P.G.; Fabien, M.; Michel, E.S.; Francoise, F.; Loetizia, F. Circ. J. 1990, 82, 105-113.
[17] Bryan, K.; Daniel, L.G.; Donald, J.S.; Steven, S.; Adrianne, B.; Catherine, S.B. Kidney Int. 2002, 61, 2157-2164.
[18] Aslam, S.; Santha, T.; Leone, A.; Wilcox, C. Kidney Int. 2006, 70, 2109-2115.
[19] Domenic, A.S.; Todd, W.B.G. Curr. Opin. Nephrol. Hypertens. 2003, 12, 123-131.
[20] Bakris, G.L.; Hart, P.; Ritz, E. Kidney Int. 2006, 70, 1905-1913.
[21] Kevin, C.A.; Fernando, C.T.; Lawrence, Y.A.; Allen, J.T.; George, L.B. Arch. Intern. Med. 2004, 164, 2465-2471.
[22] Yuya, M.; Makoto, S.; Wataru, N.; Masakazu, O.; Akihiko, M.; Yuji, H. Int. J. Cardiol. 2011, doi:10.1016.
[23] Navdeep, T.; Shani, S.C.; Hocine, T.; Gerald, J.B.; Alfred, K.C.; Garabed, E.; Mark, J.S. Am. J. Kidney Dis. 2011, 58, 939-945.
[24] Bleyer, A.J.; Hartman, J.; Brannon, P.C.; Reeves-Daniel, A.; Satko, S.G.; Russell, G. Kidney Int. 2006, 69, 2268-2273.
[25] Rajiv, A. Kidney Int. 1999, 55, 1528-1535.
[26] Inrig, J.K. Semin. Dial. 2010, 23, 290-297.
[27] Andreea-Cristina, C.; Costea, D.O.; Cristiana, D.; Grasa, C.N. J. Med. Life. 2010, 3, 67-69.
[28] Hoyer, J.; Schulte, K.L.; Lenz, T. Clin. Pharmacokinet. 1993, 24, 230-254.
[29] Gehr, T.W.B.; Sica, D.A.; Grasela, D.M.; Duchin, K.L. Eur. J. Clin. Pharmacol. 1993, 45, 431-436.
[30] Kevin, E.C.; Alp-Ikizler, T.; Jorge, L.G.; Chang, Y.; Raymond, M.H.; Nancy, J.B. Kidney Int. 2011, 80, 978-985.
[31] Fernando, E.; Cheryl, L.L. Kidney Int. 2011, 80, 911-914.
[32] Christian, W.M. Cardiovasc. Drugs Ther. 2010, 24, 139-149.
[33] Anjay, R.; Mohamad, R.; Richard, F.W. J. Clin. Hypertens. 2011, 13, 848-855.
[34] Domenic, A.S.; Todd, W.B.G. J. Renin-Angio-Aldo. S. 2002, 3, 247-254.
[35] Jennifer, L.B.; Rachel, B.F.; Nancy, A.M.; George, R.B.; Brenda, W.G.; Volker, W.; Jose, M.C.; Takashi, A.; Kiyoshi, K.; Sylvia, R.; Eric, W.Y. Am. J. Kidney Dis. 2007, 49, 426-431.